• Info
  • Insider Ownership

Insider Trading & Ownership of Rachel K. King

Location
Gaithersburg, MD
Summary
The estimated net worth of Rachel K. King is at least $2,028,198 dollars as of 30 Jun 2025. Rachel K. King is the Director of GLYCOMIMETICS INC and owns shares of CRESCENT BIOPHARMA, INC. (CBIO) stock worth about $1.55M. Rachel K. King is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $482.6K.
Signature
/s/ Alan Musso, as attorney-in-fact for Rachel King
All Insider Reports
All Insider Reports

Notify me when Rachel K. King files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Rachel K. King

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CBIO GLYCOMIMETICS INC Director $1,545,582 01 May 2024
NVAX NOVAVAX INC Director $482,616 20 Jun 2025
FULC Fulcrum Therapeutics, Inc. Director 26 Jun 2025

Insider Transactions Reported by Rachel K. King:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.